Echocardiographic limits of left ventricular remodeling in athletes  by Kasikcioglu, Erdem & Akhan, Hulya
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tefinition of Physiological
ypertrophy in Ultramarathon Athletes
e read with interest the study by Nagashima et al. (1) regarding
ignificant cardiac dilation and adaptation in ultradistance runners.
he investigators report large aortic, left atrial, and left ventricular
LV) dimensions in 291 male ultramarathon runners and found
eak relationships between heart size and body surface area (BSA)
nd significant relationships with the extent of training. It is not
urprising that heart size had only a weak relationship with BSA;
lthough heart size is related to body size, lean body mass is the
nly predictor of LV mass in adults (2) and is an important
redictor of both cardiac output and stroke volume (3).
Several studies have compared heart size as measured by
chocardiography between athletes and control subjects and re-
orted both LV hypertrophy and dilation in athletes. Some studies
ave used BSA to index echocardiographic measurements, but
one has used lean body mass. This is particularly important
ecause both endurance (4) and resistance training (5) induce
ncreases in muscle size and thus lean body mass.
It is usual, and indeed necessary, to index echocardiographic
easurements to body size in order to compare individuals of different
ody size. This can be particularly important when changes in body
omposition may be anticipated due to a pathological process or
ifestyle change. It is common for echocardiographic measurements to
e indexed to BSA (estimated from height and weight measurements)
n order to compare heart size between different-size individuals and
o establish normal ranges for detection of pathological LV hypertro-
hy. However, because BSA is affected by fat mass, and fat mass
either correlates with nor predicts LV mass (2), this method may
verestimate the degree of LV hypertrophy in lean subjects. Although
ean body mass would appear to be the optimal indexation measure, it
s rarely used, because accurate measurements are not widely available
nd substitute methods, such as skin-fold thickness measurements, are
elatively inaccurate. Height raised to various integers also correlates
ith LV size and are now widely recommended in place of BSA (6).
Echocardiography is performed in athletes primarily to deter-
ine pathological changes that might occur as a result of extensive
raining. The physiological adaptations observed in athletes are
elated to both the hemodynamic affects of exercise and overall
ody effects, including increased lean body mass. However, using
nindexed measurements, as in the study by Nagashima et al. (1),
r indeed measurements that are indexed to inappropriate body
ize measures, may lead to misleading conclusions and does not aid
ifferentiation of pathological from physiological adaptation.
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chocardiographic Limits of Left
entricular Remodeling in Athletes
e read with great interest the recently published study by
agashima et al. (1) in the November 5, 2003, issue of JACC. The
nvestigators concluded that many Japanese ultramaraton runners
ave larger left ventricle (LV) diameters (LV diastolic diameter up
o 75 mm; 33 participants had larger than 70 mm).
Nevertheless, some concern arose from previously published
eports. First, the researchers did not mention how many investi-
ators participated in the study. It is known that reproducibility of
chocardiographic measurements is important and may be an
ffective factor for LV diameter ranges.
Second, LV diastolic diameter and interventricular septum
hickness (up to 19 mm) in the study are higher than previously
entioned measures by some investigators. Maron et al. (2)
eported that maximal LV end-diastolic dimension was 66 mm,
nd maximal ventricular septal thickness was 13 mm in 947
thletes. Furthermore, they concluded that athletes with a wall
hickness more than 16 mm without LV dilation are likely to have
rimary forms of pathologic hypertrophy. Also, Douglas et al. (3)
ound that LV end-diastolic dimension was up to 65 mm and
entricular septal thickness was 14 mm in 235 athletes. The
ifferentiation of physiologic and pathologic hypertrophy can be
ifficult, but it is important in determining the existence of cardiac
isease in athletes in order to prevent exercise-related sudden
ardiac death.
Hypertrophic cardiomyopathy has to be overcome, for it is a
ifficult and important problem in athletes. It is camouflaged by
V dilation due to volume overload in endurance athletes. How-
ver, pathologic hypertrophy and dilation are probably related to a
nown characteristic of diastolic dysfunction. Recently, an easily
easured tissue Doppler index (TDI) was proposed as a poten-
ially useful method for distinguishing athlete’s heart from struc-
ural heart disease (4). We think that TDI should be routinely used
or differentiating physiological hypertrophy from the pathologic.
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uggested New Upper Limit of
hysiologic Cardiac Hypertrophy
etermined in Japanese Ultramarathon
unners Must Be Interpreted Cautiously
ith great interest and surprise we read the study by Nagashima
t al. (1). The researchers report that 11% of the participants (33
f 291) had a left ventricular end-diastolic diameter (Dd) larger
han 70 mm. In addition, further extraordinary values for the
nd-Dd (mean value, 61.8  6.9 mm; range, 42 to 75 mm), the
nd-systolic diameter (mean value, 39.6 6.9 mm; range, 23 to 55
m), and the intraventricular septal thickness (range, 5 to 19 mm)
re presented, which are in great contrast to results reported
reviously (2–5).
The data presented are even more surprising when normalized
o the body surface area (BSA; mean value, 1.66  0.1 m2),
esulting in an unbelievable mean Dd-to-BSA ratio of approxi-
ately 37 mm/m2. Such a high value seems unrealistic, especially
hen compared with the data of Pelliccia et al. (3), who found the
ighest mean Dd-to-BSA ratio of about 31 mm/m2 in healthy
ndurance athletes competing at national and international levels
59 track-and-field athletes, 49 cyclists, and 41 cross-country
kiers). Also, the range of the intraventricular septal thickness (5 to
9 mm) is suspicious for at least some pathologically hypertrophied
earts. Consequently, based on the data of previous reports (2–6),
earts with an end-Dd 60 mm or an intraventricular septal
hickness 13 mm in athletes with a BSA 1.82 m2 are highly
uspicious for pathologic hypertrophy (2) and would have required
urther cardiologic examinations to confirm the statement of a
hysiologic hypertrophy. Therefore, the data presented by Na-
ashima et al. (1) suggesting a new upper limit of physiologic
ardiac hypertrophy may lead to confusion and to misinterpreta-
ions in daily routine (diagnosis of athlete’s heart instead of
athologic hypertrophy), and put athletes at an avoidable risk.The main confounding variable of the study (1) seems to be the
ge of the subjects (mean age, 41.8  9.7 years; range, 20 to 73
ears). As it is well known that the incidence of cardiovascular
iseases rises with age (especially above 35 to 40 years) (7),
ardiovascular diseases in the participants should have been ex-
luded by cardiologic examinations. It is not sufficient to assess the
tate of an athlete’s health by taking only the resting blood pressure
r replies to questionnaires (1). Furthermore, relevant additional
xaminations should have been performed, and important param-
ters should have been given in the study: ejection fraction to
escribe the systolic function; E/A ratio to evaluate the diastolic
unction; Doppler-echocardiography to exclude valvular diseases
esulting in pathologic ventricular overload and dilation; 12-lead
lectrocardiogram at rest and exercise (including blood pressure
easurements) to detect possible coronary artery disease or
xercise-related hypertension; and spiroergometry to obtain max-
mal oxygen consumption, which describes the state of physical
tness and is closely related to cardiac dimensions [8–10]. More-
ver, the convention of echocardiographic measures is not given
Penn or American Society of Echocardiography convention
11,12]).
In conclusion, it seems that the study by Nagashima and
o-workers does not define a new upper limit (which now would be
0 mm or even 75 mm, when the 95% confidence interval for the
eft ventricular end-Dd is calculated), but a wrong upper limit of
hysiologic cardiac hypertrophy.
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